Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Functional over-redundancy and high functional vulnerability in global fish faunas on tropical reefs
2014
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Safety and efficacy of the multidrug resistance inhibitor Incel (biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxel.
2002
Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist
1999 Standout
Breast cancer
2016 Standout
CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group.
1998
Clinical and Genetic Features of Ehlers–Danlos Syndrome Type IV, the Vascular Type
2000 Standout
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Immunological and endocrinological abnormalities in paraneoplastic disorders with involvement of the autonomic nervous system
1997
Neurologic disorders in 432 consecutive patients with small cell lung carcinoma
2004
Cancer drug resistance: an evolving paradigm
2013 Standout
Recommended diagnostic criteria for paraneoplastic neurological syndromes
2004 Standout
Coral reefs in the Anthropocene
2017 StandoutNature
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement
2015 Standout
Estrogen‐mediated post transcriptional down‐regulation of P‐glycoprotein in MDR1‐transduced human breast cancer cells
2006
Phase II study of tariquidar, a selective P‐glycoprotein inhibitor, in patients with chemotherapy‐resistant, advanced breast carcinoma
2005
Cancer genes and the pathways they control
2004 Standout
Tamoxifen in the Treatment of Breast Cancer
1988
Targeting multidrug resistance in cancer
2006 Standout
Therapy for paraneoplastic neurologic syndromes in six patients with protein a column immunoadsorption
1995
Obstetrical problems in patients with Ehlers-Danlos syndrome type IV; a case report
1989
Combinatorial molecular optimization of cement hydrates
2014
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Paraneoplasia and Autoimmunologic Injury of the Nervous System: The Anti‐Hu Syndrome
1993
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic review
2009
Towards sustainable concrete
2017 Standout
Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma
2007
Overview of the clinical efficacy of investigational anticancer drugs
2003
Impact of Prior Cancer on Eligibility for Lung Cancer Clinical Trials
2014
Perioperative Screening for Metastatic Disease is not Indicated in Patients with Primary Breast Cancer and no Clinical Signs of Tumor Spread
2003
Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.
1992
Primary Analysis of a Phase II Randomized Trial Radiation Therapy Oncology Group (RTOG) 0212: Impact of Different Total Doses and Schedules of Prophylactic Cranial Irradiation on Chronic Neurotoxicity and Quality of Life for Patients With Limited-Disease Small-Cell Lung Cancer
2010
Reduced intensity allogeneic hematopoietic cell transplantation can induce durable remission in heavily pretreated relapsed Hodgkin lymphoma
2011
The cerebellar cognitive affective syndrome
1998 Standout
Salvage Therapy for Relapsed/Refractory Diffuse Large B Cell Lymphoma
2008
Development of Multidrug-Resistance Convertors: Sense or Nonsense?
2000
1H NMR spin-spin relaxation and imaging in porous systems: an application to the morphological study of white portland cement during hydration in the presence of organics
2004
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804
2007
A Study in Contrasts: Eligibility Criteria in a Twenty-Year Sample of NSABP and POG Clinical Trials
1998
Current Standards of Care in Small-Cell and Non-Small-Cell Lung Cancer
2001
Serum CEA and CA 15-3 as prognostic factors in primary breast cancer
2002
Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients
2000 Standout
Industry sponsorship and research outcome
2012 Standout
Antibody-Mediated Encephalitis
2018 Standout
Calcined clay limestone cements (LC3)
2017 Standout
3D printing using concrete extrusion: A roadmap for research
2018 Standout
Utility of subsequent conventional dose chemotherapy in relapsed/refractory transplant-eligible patients with diffuse large B-cell lymphoma failing platinum-based salvage chemotherapy
2008
Tumour stem cells and drug resistance
2005 Standout
Advances in understanding hydration of Portland cement
2015 Standout
Drying-induced changes in the structure of alkali-activated pastes
2013
PREGNANCY COMPLICATIONS IN TYPE IV EHLERS-DANLOS SYNDROME
1983
Basic Guide to the Mechanisms of Antiestrogen Action
1998
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Advances in understanding alkali-activated materials
2015 Standout
Recent development in the treatment of oily sludge from petroleum industry: A review
2013 Standout
The ternary system Portland cement–calcium sulphoaluminate clinker–anhydrite: Hydration mechanism and mortar properties
2010
Vision of 3D printing with concrete — Technical, economic and environmental potentials
2018 Standout
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
1992 Standout
Mechanisms of Estrogen Action
2001 Standout
The influence of water absorption and porosity on the deterioration of cement paste and concrete exposed to elevated temperatures, as in a fire event
2012
An overview of thermal energy storage systems
2017 Standout
C4A3Š hydration in different alkaline media
2013
Eco-efficient cements: Potential economically viable solutions for a low-CO2 cement-based materials industry
2018 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Mechanical properties of concrete at high temperature—A review
2015 Standout
The electron cyclotron maser
2004 Standout
Cement substitution by a combination of metakaolin and limestone
2012 Standout
Effect of drying on cement-based materials pore structure as identified by mercury intrusion porosimetry
2001 Standout
Calcium aluminate based cement for concrete to be used as thermal energy storage in solar thermal electricity plants
2016
Nanotechnology in concrete – A review
2010 Standout
Carcinoembryonic Antigen (CEA) in the Follow-Up of Disease-Free Breast Cancer Patients
1982
Advances in alternative cementitious binders
2010 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Hydration and rheology control of concrete for digital fabrication: Potential admixtures and cement chemistry
2018
Effect of fly ash fineness on microstructure of blended cement paste
2006 Standout
Selective Estrogen Receptor Modulators: Clinical Spectrum*
1999
Drug Resistance in Cancer: An Overview
2014 Standout
What treatment for elderly patients with aggressive lymphoma?
1994
Modification of phase evolution in alkali-activated blast furnace slag by the incorporation of fly ash
2013 Standout
Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
2014 Standout
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Industry sponsorship and research outcome
2017 Standout
Circumventing Cancer Drug Resistance in the Era of Personalized Medicine
2012
Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial
2011
Works of Robert E. Myers being referenced
Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B‐cell non‐Hodgkin lymphoma
2004
Neurologic disorders in patients with small cell lung cancer
1987
Gemcitabine, dexamethasone and cisplatin is an active andnon-toxic chemotherapy regimen in relapsed or refractory Hodgkin’s disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group
2003
Global Biogeography of Reef Fishes: A Hierarchical Quantitative Delineation of Regions
2013
A Phase II Trial of Prednisone, Oral Etoposide, and Novantrone (PEN) as Initial Treatment of Non-Hodgkin's Lymphoma in Elderly Patients
1995
Reasons for non‐entry in randomized clinical trials for breast cancer: A single institutional study
1992
Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511)
2001
Prednisone, oral etoposide, and novantrone for treatment of non-Hodgkin's lymphoma: a preliminary report.
1994
Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimen.
1998
High-power millimeter-wave transmitter for the NRL WARLOC radar
2003
Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast carcinoma.
1986
Carcinoembryonic antigen in breast cancer
1978
Early Strength Development and Hydration of Ordinary Portland Cement/Calcium Aluminate Cement Pastes
1997
Connective tissue disorders in obstetrics and gynecology
1968
Global patterns and predictors of tropical reef fish species richness
2013
Solvent Replacement Studies of Hydrated Portland Cement Systems: The Role of Calcium Hydroxide
1998
Baseline staging tests in primary breast cancer: a practice guideline.
2001
Surface area of cement paste conditioned at various relative humidities
1983
The Fracture of C-S-H and C-S-H/CH Mixtures
1998